Every material Form 8-K Quaker Chemical filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Quaker Chemical reported third-quarter 2025 net sales of $493.8 million, up 7% from a year earlier, driven by acquisitions, 3% organic volume growth and new business wins. GAAP net income and diluted earnings per share fell slightly from the prior year, while non-GAAP earnings per diluted share rose 10% to $2.08. Management expects year-over-year revenue and earnings growth in the fourth quarter, but said the soft operating environment will persist at least through year end.
Q3 2025 net sales were $493.8 million, up from $462.3 million in Q3 2024.
Q3 GAAP net income was $30.5 million, or $1.75 per diluted share, versus $32.3 million, or $1.81, a year earlier.
Non-GAAP earnings per diluted share were $2.08, compared with $1.89 in Q3 2024.
For the nine months ended September 30, 2025, the company reported a net loss of $23.2 million, including $88.8 million of impairment charges.
Quaker Houghton reported second-quarter 2025 net sales of $483.4 million, up 4% from a year earlier, but posted a net loss of $66.6 million, or $3.78 per diluted share, driven by an $88.8 million non-cash goodwill impairment tied to its EMEA segment. Non-GAAP earnings per diluted share fell to $1.71 from $2.13, and management expects a stronger second half with full-year 2025 revenue and earnings in the range of 2024.
Net sales rose 4% to $483.4 million from $463.6 million, with organic sales volumes up 2%.
Net loss of $66.6 million, or $3.78 per diluted share, compared with net income of $34.9 million a year earlier.
Non-GAAP earnings per diluted share were $1.71 versus $2.13; adjusted EBITDA was $75.5 million, down about 10%.
Management expects full-year 2025 revenue and earnings in the range of 2024 and about $20 million of run-rate cost savings by the end of 2026.
Quaker Chemical said Chief Accounting Officer Jeffrey Kutz resigned effective July 18, 2025, in a voluntary departure not tied to any disagreement with the company. Vice President and Corporate Controller Steve Dassing will also serve as Principal Accounting Officer, with his base salary set at $300,000 effective July 20, 2025.
Jeffrey Kutz resigned as Vice President, Chief Accounting Officer effective July 18, 2025; the filing says the departure was voluntary and not related to any disagreement.
Steve Dassing, age 39, will serve as Principal Accounting Officer in addition to his role as Vice President, Corporate Controller, which he has held since July 2024.
Dassing's base salary was set at $300,000 per year; his 2025 AIP target is 35% of base salary, and his long-term incentive target value is $110,000.
Quaker Chemical said director Ramaswami Seshasayee retired from its Board of Directors effective May 14, 2025, in a voluntary decision not tied to any disagreement with the company. The Board size was reduced from twelve to eleven directors, effective immediately. The filing describes a routine board change and does not mention any financial results or outlook.
Ramaswami Seshasayee retired from the Board effective May 14, 2025.
He had served on the Board since 2019 and sat on the Audit and Compensation and Human Resources Committees.
Board size reduced from twelve to eleven directors, effective immediately.
The filing states the retirement was voluntary and not due to any disagreement with the company.
Quaker Houghton reported first-quarter 2025 net sales of $442.9 million, down about 6% from $469.8 million a year earlier, and net income of $12.9 million, or $0.73 per diluted share, versus $35.2 million, or $1.95, in the prior-year quarter. Management said it expects revenue and earnings in 2025 to be in line with 2024, citing ongoing weak end-market demand and tariff uncertainty.
Net sales were $442.9 million, down about 6% from $469.8 million, with sales volumes down 3%.
Net income was $12.9 million, or $0.73 per diluted share, versus $35.2 million, or $1.95; non-GAAP earnings per diluted share were $1.58 versus $2.09.
Adjusted EBITDA was $69.0 million, down 17% from $83.3 million, and net cash used by operating activities was $3.1 million versus $27.2 million provided a year earlier.
The company acquired Dipsol Chemicals for about $155.2 million in April 2025, funded with borrowings under its existing credit facility.
Quaker Houghton reported fourth quarter and full year 2024 results on February 24, 2025. Q4 net sales fell 5% to $444.1 million and diluted EPS fell to $0.81 from $1.12, while full year net income rose to $116.6 million and diluted EPS rose to $6.51 from $6.26, even though full year net sales declined to $1.84 billion from $1.95 billion.
Q4 2024 net sales were $444.1 million, down from $467.1 million in Q4 2023; Q4 net income was $14.2 million, or $0.81 per diluted share, versus $20.2 million, or $1.12, a year earlier
Q4 adjusted EBITDA was $64.8 million, down about 16% from $77.0 million, driven by lower sales and operating margins
Full year 2024 net income was $116.6 million, or $6.51 per diluted share, compared with $112.7 million, or $6.26, in 2023; full year net sales were $1.84 billion versus $1.95 billion
The company expects run-rate cost savings of at least $20 million in 2025 and said it expects revenue, adjusted EBITDA and earnings growth in 2025, but did not provide formal GAAP guidance
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Quaker Chemical filing is on SEC EDGAR ↗. 8-K briefs of other companies →